Exercise hemodynamics and mitochondrial oxidative capacity in disease stages of wild-type transthyretin amyloid cardiomyopathy.

11 May 2024 (11:00 - 11:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Bertil Ladefoged

Aarhus University Hospital, Aarhus (Denmark)

7 More presentations in this session

Presentation thumbnail

Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life

Doctor R. Rascon Sabido (Veracruz, MX)

Abstract Slides Video

Presentation thumbnail

Correlation of sST2 with chosen biochemical parameters and influence on prognosis in patients hospitalized due to HFrEF.

Doctor M. Dudek (Poznan, PL)

Abstract Slides Video

Presentation thumbnail

Long-term hydroxychloroquine exposure impairs the left ventricular longitudinal strain

Doctor R. Didier (Dijon, FR)

Abstract Slides Video

Presentation thumbnail

Exrecise capacity dynamics in non-hodgkin lymphoma patients

Doctor D. Bursacovschi (Chisinau, MD)

Abstract Slides Video

Presentation thumbnail

The impact of antitumor therapy on cardiac systolic function in patients with non-hodgkin lymphoma

Doctor D. Bursacovschi (Chisinau, MD)

Abstract Slides Video

Access the full session

Session thumbnail

Chronic heart failure - pathophysiology and mechanisms 3

The Event

Event poster

Heart Failure 2024

11 May 2024 11:00 CET

You may be interested in

Congress Presentation

A characterisation of mitochondrial structure, oxidative phosphorylation capacity, and amyloid burden in patients with wild-type transthyretin cardiomyopathy

Congress Presentation

The role of CPET for the assessment of patients with transthyretin amyloid cardiomyopathy

Congress Presentation

Neurological and cardiological profiling of patients with mutated transthyretin amyloidosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources